Suppr超能文献

头颈部癌调强放射治疗的脑保护方法。

Brain-sparing methods for IMRT of head and neck cancer.

作者信息

Dunlop Alex, Welsh Liam, McQuaid Dualta, Dean Jamie, Gulliford Sarah, Hansen Vibeke, Bhide Shreerang, Nutting Chris, Harrington Kevin, Newbold Kate

机构信息

Joint Department of Physics, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom.

The Royal Marsden Hospital, London, United Kingdom; The Institute of Cancer Research, London, United Kingdom.

出版信息

PLoS One. 2015 Mar 17;10(3):e0120141. doi: 10.1371/journal.pone.0120141. eCollection 2015.

Abstract

PURPOSE

Radical radiotherapy for head and neck cancer (HNC) may deliver significant doses to brain structures. There is evidence that this may cause a decline in neurocognitive function (NCF). Radiation dose to the medial temporal lobes, and particularly to the hippocampi, seems to be critical in determining NCF outcomes. We evaluated the feasibility of two alternative intensity-modulated radiotherapy (IMRT) techniques to generate hippocampus- and brain-sparing HNC treatment plans to preserve NCF.

METHODS AND MATERIALS

A planning study was undertaken for ten patients with HNC whose planning target volume (PTV) included the nasopharynx. Patients had been previously treated using standard (chemo)-IMRT techniques. Bilateral hippocampi were delineated according to the RTOG atlas, on T1w MRI co-registered to the RT planning CT. Hippocampus-sparing plans (HSRT), and whole-brain/hippocampus-sparing fixed-field non-coplanar IMRT (BSRT) plans, were generated. DVHs and dose difference maps were used to compare plans. NTCP calculations for NCF impairment, based on hippocampal dosimetry, were performed for all plans.

RESULTS

Significant reductions in hippocampal doses relative to standard plans were achieved in eight of ten cases for both HSRT and BSRT. EQD2 D40% to bilateral hippocampi was significantly reduced from a mean of 23.5 Gy (range 14.5-35.0) in the standard plans to a mean of 8.6 Gy (4.2-24.7) for HSRT (p = 0.001) and a mean of 9.0 Gy (4.3-17.3) for BSRT (p < 0.001). Both HSRT and BSRT resulted in a significant reduction in doses to the whole brain, brain stem, and cerebellum.

CONCLUSION

We demonstrate that IMRT plans for HNC involving the nasopharynx can be successfully optimised to significantly reduce dose to the bilateral hippocampi and whole brain. The magnitude of the achievable dose reductions results in significant reductions in the probability of radiation-induced NCF decline. These results could readily be translated into a future clinical trial.

摘要

目的

头颈部癌(HNC)的根治性放射治疗可能会给脑结构带来显著剂量。有证据表明这可能导致神经认知功能(NCF)下降。内侧颞叶,尤其是海马体的辐射剂量,似乎在决定NCF结果方面至关重要。我们评估了两种替代的调强放射治疗(IMRT)技术生成保留海马体和脑的HNC治疗计划以保留NCF的可行性。

方法和材料

对10名头颈部癌患者进行了一项计划研究,其计划靶区(PTV)包括鼻咽部。患者此前曾使用标准(化疗)IMRT技术进行治疗。根据RTOG图谱在与放疗计划CT共同配准的T1加权MRI上勾勒出双侧海马体。生成了保留海马体的计划(HSRT)和全脑/海马体保留固定野非共面IMRT(BSRT)计划。使用剂量体积直方图(DVH)和剂量差异图来比较计划。基于海马体剂量测定对所有计划进行了NCF损伤的正常组织并发症概率(NTCP)计算。

结果

对于HSRT和BSRT,10例患者中有8例相对于标准计划海马体剂量显著降低。双侧海马体的等效均匀剂量(EQD2)D40%从标准计划的平均23.5 Gy(范围14.5 - 35.0)显著降低至HSRT的平均8.6 Gy(4.2 - 24.7)(p = 0.001)以及BSRT的平均9.0 Gy(4.3 - 17.3)(p < 0.001)。HSRT和BSRT均导致全脑、脑干和小脑的剂量显著降低。

结论

我们证明了涉及鼻咽部的HNC的IMRT计划可以成功优化,以显著降低双侧海马体和全脑的剂量。可实现的剂量降低幅度导致辐射诱导的NCF下降概率显著降低。这些结果可以很容易地转化为未来的临床试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d837/4364536/69415e282a83/pone.0120141.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验